Shares of Kaya, known for its dermatological solutions, hit the 10% upper circuit after announcing a collaboration with Marico.
Marico will now handle the sales and marketing of Kaya’s 75+ personal care products, sold outside of Kaya’s clinics. This partnership aims to boost Kaya’s market presence and accessibility by combining the strengths of both companies.
Kaya offers a wide range of dermatologist-recommended products, including daily essentials and specialized solutions for acne, skin brightening, sun care, anti-aging, and hair care. These products are available on e-commerce platforms and in over 70 Kaya Skin Clinics across India.
Kaya was once a part of Marico until it was separated in 2013. Now, Kaya operates independently, offering skin care services and products in India and the Middle East.
After the announcement, Kaya’s stock surged to ₹501.45 per share, increasing its market value to over ₹665.10 crore. The stock has risen more than 55% in the past year.
Kaya shares are currently under the Short-term Additional Surveillance Measures (ASM) due to significant price changes and client concentration. Notably, investor Porinju Veliyath’s fund owns 2.2 lakh shares of Kaya, valued at ₹11.03 crore at the current price.
Disclaimer: The views and investment tips expressed by investment experts on Sharepriceindia.com are their own and not those of the website or its management. Sharepriceindia.com advises users to check with certified experts before taking any investment decisions.
